A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Overview
  • Protocol
  • Results
  • Disclosures
  • Materials

Overview

In this video, we demonstrate the repetitive tumor challenge assay to evaluate the CAR T cells’ repetitive tumor killing potential during high tumor cell loads. Further, the CAR T cells can be analyzed using flow cytometry to determine the different subpopulations of CAR T cells in the sample.

Protocol

1. Media Preparation

  1. Prepare neural stem cell media for culturing primary GBM cell lines: DMEM:F12, 1:50 B27, 5 µg/mL heparin, and 2 mmol/L L-glutamine; supplemented with 20 ng/mL epidermal growth factor (EGF) and 20 ng/mL basic fibroblast growth factor (FGF) twice a week (see Table of Materials).
  2. Prepare T cell media: X-VIVO 15 containing 10% fetal calf serum (FCS); supplemented with 70 IU/mL rhIL-2 and 0.5 ng/mL rhIL-15 every 48 h (see Table of Materials).
  3. Prepare co-culture media: take neural stem cell media without EGF and FGF supplement, and add 10% FCS.
  4. Pr....

Results

figure-results-58
Figure 1: Schema and analysis strategy of repetitive challenge assay. (A) Schema and timeline of repetitive tumor challenge assay. For each well, CAR T cells were first co-cultured with PBT030-2 GBM cells (4,000 CAR+ cells, 16,000 tumor cells) and re-challenged with 32,000 tumor cells every other day (D2, D4 and D6). Analysis of tumor cell and CAR T cell number, as well as C.......

Disclosures

No conflicts of interest declared.

Materials

NameCompanyCatalog NumberComments
0.05% Trypsin/0.53mM EDTA in HBSS without Calcium and MagnesiumCorningMT25051CI
1 M HepesIrvine Scientific9319
200 mM L-GlutamineCambrex Bio Science17-605E
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) - FluoroPure gradeInvitrogenD21490
AccutaseInnovative Cell TechnologiesAT104
Aldesleukin Proleukin (rhIL-2)Novartis OncologyNDC 0078-0495-61
Anti-CD137, PEBD Biosciences5559564B4-1
Anti-CD19, PE-Cy7BD Biosciences557835SJ25C1
Anti-CD3, PERCPBD Biosciences340663SK7
Anti-CD4, FITCBD Biosciences340133SK3
Anti-CD45, PERCPBD Biosciences3406652D1
Anti-CD45RO, PEBD Biosciences561137UCHL1
Anti-CD62L, APCBD Biosciences559772DREG-56
Anti-CD69, APCBD Biosciences340560L78
Anti-CD8, APC-Cy7BD Biosciences348793SK1
Anti-IL-13, PEBD Biosciences340508JES10-5A2
Anti-LAG-3, PEeBiosciences12-2239-413DS223H
Anti-PD-1, APC-Cy7BioLegend329921EH12.2H7
Anti-TIM-3, APCeBiosciences17-3109-42F38-2E2
B-27 Serum-Free Supplement (50x)Invitrogen17504-044
Corning 96 Well Clear Flat Bottom Polystyrene TC-Treated Microplates, Individually Wrapped, with Lid, Sterile (Product #3596)Corning Life Sciences3596
Defined fetal bovine serum,HI IRHyclone LabsSH30070.03IH
DMEM F-12 50:50 (1x) without GlutamineMediaTech, Inc.15-090-CV
DMEM High Gluc w/o L-Glu, Na Pyr 1 LInvitrogen11960051
DMEM-Ham's F12 50:50 Mixture with L-glutamine and 15 mM HEPESFisher ScientificMT10092CV
HBSSIrvine Scientific9224
Heat-Inactivated FCSHycloneSH30070.03
Heparin Sodium(1,000 U/mL)American Pharmaceutical401811B
PBS 1x W/CA & MGIrvine Scientific9236
PBS with 1 mM EDTA (No Ca2+ or Mg2+)VWR Scientific ProductsPB15009A
rhIL-15 Working Dilution (10 ng/µL)CellGenix, US OperationstF0297
Sodium Azide (NaN3)SigmaS8032
Recombinant human EGF  R&D Systems236-EG-200
Recombinant human FGF R&D Systems233-FB

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved